Alhydroxiquim-II adjuvant enhances efficacy of India's COVID-19 vaccine
An adjuvant developed with funding from the National Institutes of Health has contributed to the success of the highly efficacious COVAXIN COVID-19 vaccine, which roughly 25 million people have received to date in India and ...
Jun 30, 2021
0
2